Pomanda estimates the enterprise value of RAPID LIFE SCIENCES LTD at £155.1k based on a Turnover of £277.6k and 0.56x industry multiple (adjusted for size and gross margin).
rapid life sciences ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of RAPID LIFE SCIENCES LTD at £0 based on an EBITDA of £-84.2k and a 3.24x industry multiple (adjusted for size and gross margin).
rapid life sciences ltdEstimated Valuation
£29.4k
Pomanda estimates the enterprise value of RAPID LIFE SCIENCES LTD at £29.4k based on Net Assets of £17.6k and 1.67x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rapid Life Sciences LtdOverview
Rapid Life Sciences Ltd is a live company located in chester, CH4 9QP with a Companies House number of 04327046. It operates in the publishing of consumer and business journals and periodicals sector, SIC Code 58142. Founded in November 2001, it's largest shareholder is
lucy vanessa burney
with a 60.1% stake. Rapid Life Sciences Ltd is a mature,
micro sized company, Pomanda has estimated its turnover at
£277.6k with
declining
growth in recent years.
Pomanda's financial health check has awarded Rapid Life Sciences Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
0 Strong
6 Regular
5 Weak
Size
annual sales of £277.6k, make it smaller than the average company (£6.7m)
£277.6k - Rapid Life Sciences Ltd
£6.7m - Industry AVG
Growth
3 year (CAGR) sales growth of -40%, show it is growing at a slower rate (1.5%)
-40% - Rapid Life Sciences Ltd
1.5% - Industry AVG
Production
with a gross margin of 53.2%, this company has a comparable cost of product (53.2%)
53.2% - Rapid Life Sciences Ltd
53.2% - Industry AVG
Profitability
an operating margin of -30.3% make it less profitable than the average company (5.6%)
-30.3% - Rapid Life Sciences Ltd
5.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (55)
2 - Rapid Life Sciences Ltd
55 - Industry AVG
Pay Structure
on an average salary of £58k, the company has an equivalent pay structure (£58k)
£58k - Rapid Life Sciences Ltd
£58k - Industry AVG
Efficiency
resulting in sales per employee of £138.8k, this is equally as efficient (£149.5k)
£138.8k - Rapid Life Sciences Ltd
£149.5k - Industry AVG
Debtor Days
it gets paid by customers after 56 days, this is near the average (47 days)
56 days - Rapid Life Sciences Ltd
47 days - Industry AVG
Creditor Days
its suppliers are paid after 34 days, this is close to average (37 days)
34 days - Rapid Life Sciences Ltd
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Rapid Life Sciences Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 16 weeks, this is average cash available to meet short term requirements (15 weeks)
16 weeks - Rapid Life Sciences Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 91.1%, this is a higher level of debt than the average (65.2%)
91.1% - Rapid Life Sciences Ltd
65.2% - Industry AVG
RAPID LIFE SCIENCES LTD financials
EXPORT
Rapid Life Sciences Ltd's latest turnover from December 2023 is estimated at £277.6 thousand and the company has net assets of £17.6 thousand. According to their latest financial statements, Rapid Life Sciences Ltd has 2 employees and maintains cash reserves of £55.7 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
277,584
283,518
303,012
1,306,199
889,521
1,894,992
2,204,276
2,300,915
7,235,334
5,462,638
3,966,257
2,804,888
2,702,661
2,566,769
251,421
Other Income Or Grants
Cost Of Sales
129,957
124,699
130,896
569,314
412,743
947,060
1,165,627
1,222,697
3,847,396
2,863,585
2,052,875
1,518,126
1,359,204
1,297,742
Gross Profit
147,627
158,819
172,116
736,886
476,778
947,932
1,038,648
1,078,219
3,387,939
2,599,054
1,913,382
1,286,762
1,343,457
1,269,027
251,421
Admin Expenses
231,860
126,169
217,189
594,319
491,728
945,176
1,025,899
1,087,282
3,379,968
2,586,004
1,898,291
1,286,792
1,325,742
1,275,348
226,058
Operating Profit
-84,233
32,650
-45,073
142,567
-14,950
2,756
12,749
-9,063
7,971
13,050
15,091
-30
17,715
-6,321
25,363
Interest Payable
Interest Receivable
2,499
1,457
55
23
32
24
44
83
82
Pre-Tax Profit
-81,734
34,107
-45,018
142,567
-14,950
2,756
12,749
-9,063
7,994
13,082
15,116
14
17,797
-6,239
25,363
Tax
-6,480
-27,088
-524
-2,422
-1,599
-2,747
-3,477
-3
-4,627
Profit After Tax
-81,734
27,627
-45,018
115,479
-14,950
2,232
10,327
-9,063
6,395
10,335
11,639
11
13,170
-6,239
25,363
Dividends Paid
Retained Profit
-81,734
27,627
-45,018
115,479
-14,950
2,232
10,327
-9,063
6,395
10,335
11,639
11
13,170
-6,239
25,363
Employee Costs
116,073
110,545
53,689
564,141
356,529
724,646
824,532
868,154
2,582,287
1,851,444
1,349,552
979,540
1,006,953
938,674
Number Of Employees
2
2
1
11
7
15
17
18
54
41
30
22
22
22
EBITDA*
-84,233
32,650
-45,073
142,567
-14,950
2,756
12,749
-9,063
7,971
13,050
15,091
-30
17,715
-6,321
26,113
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
750
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
47,960
46,933
46,013
Total Fixed Assets
47,960
46,933
46,013
750
Stock & work in progress
Trade Debtors
42,967
49,466
62,398
192,291
119,676
277,289
308,793
316,822
994,628
792,909
545,826
371,905
382,240
362,583
33,611
Group Debtors
268,025
Misc Debtors
50,448
22,407
15,252
178
Cash
55,725
39,461
43,794
9,185
3,592
6,082
11,678
21,374
11,423
misc current assets
total current assets
149,140
111,334
121,444
192,291
119,676
277,289
308,793
316,822
994,628
802,094
549,418
377,987
393,918
383,957
313,237
total assets
197,100
158,267
167,457
192,291
119,676
277,289
308,793
316,822
994,628
802,094
549,418
377,987
393,918
383,957
313,987
Bank overdraft
Bank loan
Trade Creditors
12,156
14,641
65,219
76,139
119,003
261,666
295,402
313,758
982,501
796,262
553,921
394,129
410,071
413,280
14,055
Group/Directors Accounts
319,338
other short term finances
hp & lease commitments
other current liabilities
167,367
44,315
30,554
3,678
total current liabilities
179,523
58,956
95,773
76,139
119,003
261,666
295,402
313,758
982,501
796,262
553,921
394,129
410,071
413,280
337,071
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
179,523
58,956
95,773
76,139
119,003
261,666
295,402
313,758
982,501
796,262
553,921
394,129
410,071
413,280
337,071
net assets
17,577
99,311
71,684
116,152
673
15,623
13,391
3,064
12,127
5,832
-4,503
-16,142
-16,153
-29,323
-23,084
total shareholders funds
17,577
99,311
71,684
116,152
673
15,623
13,391
3,064
12,127
5,832
-4,503
-16,142
-16,153
-29,323
-23,084
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
-84,233
32,650
-45,073
142,567
-14,950
2,756
12,749
-9,063
7,971
13,050
15,091
-30
17,715
-6,321
25,363
Depreciation
750
Amortisation
Tax
-6,480
-27,088
-524
-2,422
-1,599
-2,747
-3,477
-3
-4,627
Stock
Debtors
22,569
-4,857
-68,628
72,615
-157,613
-31,504
-8,029
-677,806
201,719
247,083
173,921
-10,335
19,657
60,769
301,814
Creditors
-2,485
-50,578
-10,920
-42,864
-142,663
-33,736
-18,356
-668,743
186,239
242,341
159,792
-15,942
-3,209
399,225
14,055
Accruals and Deferred Income
123,052
13,761
30,554
-3,678
3,678
Deferred Taxes & Provisions
Cash flow from operations
13,765
-5,790
43,189
-9,108
5,561
-2,515
-5,640
-9,778
328,457
-257,968
Investing Activities
capital expenditure
750
-1,500
Change in Investments
cash flow from investments
750
-1,500
Financing Activities
Bank loans
Group/Directors Accounts
-319,338
319,338
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
550
-100
-48,447
interest
2,499
1,457
55
23
32
24
44
83
82
cash flow from financing
2,499
1,457
605
-77
32
24
44
83
-319,256
270,891
cash and cash equivalents
cash
16,264
-4,333
43,794
-9,185
5,593
-2,490
-5,596
-9,696
9,951
11,423
overdraft
change in cash
16,264
-4,333
43,794
-9,185
5,593
-2,490
-5,596
-9,696
9,951
11,423
rapid life sciences ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for rapid life sciences ltd. Get real-time insights into rapid life sciences ltd's credit score, group structure and payment trends.
Perform a competitor analysis for rapid life sciences ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other micro companies, companies in CH4 area or any other competitors across 12 key performance metrics.
rapid life sciences ltd Ownership
RAPID LIFE SCIENCES LTD group structure
Rapid Life Sciences Ltd has no subsidiary companies.
Ultimate parent company
RAPID LIFE SCIENCES LTD
04327046
RAPID LIFE SCIENCES LTD Shareholders
The largest shareholders in Rapid Life Sciences Ltd include Lucy Vanessa Burney and Nigel Dennistoun Burney.
lucy vanessa burney
60.1%
nigel dennistoun burney
28.89%
duncan alexander wood
10.55%
joanna perry-plant
0.39%
rod jones
0.07%
rapid life sciences ltd directors
Rapid Life Sciences Ltd currently has 3 directors.
The longest serving directors include
Mr Duncan Wood (Apr 2017) and
Sir Nigel Burney (Mar 2020).
58142 - Publishing of consumer, business and professional journals and periodicals
incorporation date
November 2001
age
24
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
controlled media limited (April 2013)
accountant
-
auditor
-
address
no.3 office village, chester business park, chester, cheshire, CH4 9QP
Bank
-
Legal Advisor
-
rapid life sciences ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to rapid life sciences ltd.
rapid life sciences ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RAPID LIFE SCIENCES LTD. This can take several minutes, an email will notify you when this has completed.
rapid life sciences ltdCompanies House Filings - See Documents
